Case Study: Thomson Reuters modernizes JPharm and improves collaboration with NIX

Thomson Reuters modernizes JPharm with Nix’s 19-expert team

Thomson Reuters, a global provider of pharmaceutical and business intelligence solutions, faced significant challenges with its internal JPharm collaboration platform. The legacy system was difficult to maintain, lacked documentation, and its disjointed data sources hindered real-time updates for its global editors. Vendor NIX was engaged to modernize the platform and assess its quality.

NIX reverse-engineered the entire system to create comprehensive documentation and a modernization roadmap. They then reconstructed the platform's components, developing new data-loading modules that streamlined the editorial process. The result was a high-functioning JPharm platform with reinforced architecture and enriched functionality, enabling editors to upload data effortlessly and automatically. NIX delivered these tangible results in a short timeframe.

Thomson Reuters